Mike Matson
Stock Analyst at Needham
(3.21)
# 1,068
Out of 5,147 analysts
559
Total ratings
44.37%
Success rate
2.39%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Buy | $26 → $30 | $19.17 | +56.49% | 25 | Feb 27, 2026 | |
| PSNL Personalis | Maintains: Buy | $10 → $12 | $9.06 | +32.45% | 22 | Feb 27, 2026 | |
| VCYT Veracyte | Maintains: Buy | $44 → $48 | $36.59 | +31.18% | 19 | Feb 26, 2026 | |
| ENOV Enovis | Maintains: Buy | $49 → $52 | $25.47 | +104.16% | 17 | Feb 26, 2026 | |
| TFX Teleflex | Maintains: Buy | $138 → $147 | $122.06 | +20.43% | 11 | Feb 26, 2026 | |
| LIVN LivaNova | Maintains: Buy | $64 → $81 | $70.60 | +14.73% | 28 | Feb 25, 2026 | |
| MMSI Merit Medical Systems | Maintains: Buy | $108 → $101 | $77.18 | +30.86% | 33 | Feb 25, 2026 | |
| TMDX TransMedics Group | Maintains: Buy | $166 → $174 | $145.26 | +19.79% | 15 | Feb 25, 2026 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $84 → $86 | $78.70 | +9.28% | 7 | Feb 24, 2026 | |
| MDT Medtronic | Maintains: Buy | $121 → $120 | $97.66 | +22.88% | 23 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $9.83 | +52.59% | 29 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $31.26 | +43.95% | 36 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $98.44 | - | 27 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $121 → $97 | $76.85 | +26.22% | 35 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $38.50 | +50.65% | 21 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $448 → $454 | $387.46 | +17.17% | 11 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $46.00 | - | 26 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $344.39 | - | 14 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $63.32 | - | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.44 | +108.33% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.25 → $9 | $6.01 | +49.75% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $75.36 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $13.75 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.10 | +96.72% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $175.35 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $150.58 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $252.35 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $256.26 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $15.52 | +170.62% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $95.46 | -21.43% | 1 | Feb 18, 2021 |
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $26 → $30
Current: $19.17
Upside: +56.49%
Personalis
Feb 27, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $9.06
Upside: +32.45%
Veracyte
Feb 26, 2026
Maintains: Buy
Price Target: $44 → $48
Current: $36.59
Upside: +31.18%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $49 → $52
Current: $25.47
Upside: +104.16%
Teleflex
Feb 26, 2026
Maintains: Buy
Price Target: $138 → $147
Current: $122.06
Upside: +20.43%
LivaNova
Feb 25, 2026
Maintains: Buy
Price Target: $64 → $81
Current: $70.60
Upside: +14.73%
Merit Medical Systems
Feb 25, 2026
Maintains: Buy
Price Target: $108 → $101
Current: $77.18
Upside: +30.86%
TransMedics Group
Feb 25, 2026
Maintains: Buy
Price Target: $166 → $174
Current: $145.26
Upside: +19.79%
Establishment Labs Holdings
Feb 24, 2026
Maintains: Buy
Price Target: $84 → $86
Current: $78.70
Upside: +9.28%
Medtronic
Feb 17, 2026
Maintains: Buy
Price Target: $121 → $120
Current: $97.66
Upside: +22.88%
Feb 17, 2026
Maintains: Buy
Price Target: $14 → $15
Current: $9.83
Upside: +52.59%
Feb 12, 2026
Reiterates: Buy
Price Target: $45
Current: $31.26
Upside: +43.95%
Feb 10, 2026
Reiterates: Hold
Price Target: n/a
Current: $98.44
Upside: -
Feb 5, 2026
Maintains: Buy
Price Target: $121 → $97
Current: $76.85
Upside: +26.22%
Feb 2, 2026
Reiterates: Buy
Price Target: $58
Current: $38.50
Upside: +50.65%
Jan 30, 2026
Maintains: Buy
Price Target: $448 → $454
Current: $387.46
Upside: +17.17%
Jan 29, 2026
Reiterates: Hold
Price Target: n/a
Current: $46.00
Upside: -
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $344.39
Upside: -
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $63.32
Upside: -
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.44
Upside: +108.33%
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $6.01
Upside: +49.75%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $75.36
Upside: -
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $13.75
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.10
Upside: +96.72%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $175.35
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $150.58
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $252.35
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $256.26
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $15.52
Upside: +170.62%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $95.46
Upside: -21.43%